February 23, 2023 | The Legal Intelligencer
OIG: Hospital's NPs Fell Under 'Safe Harbor' Provision of Anti-Kickback StatuteThis advisory opinion addressed a proposed arrangement by the hospital under which the hospital employs NPs to assist participating physicians and allows these NPs to perform a wide range of tasks and services that were traditionally only performed by physicians.
By Vasilios J. (Bill) Kalogredis
8 minute read
November 28, 2022 | The Legal Intelligencer
CMS Expands Access to Merit-Based Incentive Payment System HistoryIn October, the Centers for Medicare & Medicaid Services (CMS) expanded the archive for doctors and clinicians (DAC) on the provider data catalog (PDC) to provide access to merit-based incentive payment system (MIPS) program performance data from all previous years that were publicly reported on Care Compare and the PDC.
By Vasilios J. (Bill) Kalogredis
7 minute read
August 29, 2022 | The Legal Intelligencer
US Supreme Court Sides With 340B Hospitals in Drug-Pricing Program CaseIn a unanimous opinion delivered by Justice Brett Kavanaugh on June 15, the U.S. Supreme Court sided with hospitals and held that Medicaid funding was unlawfully cut to certain hospital groups. In the American Hospital Association v. Becerra holding, the Supreme Court has made it clear that the cuts in 2018 and 2019 to only one group of hospitals is contrary to the associated reimbursement statute and unlawful.
By Vasilios J. (Bill) Kalogredis
7 minute read
January 24, 2022 | The Legal Intelligencer
OIG: Free Eye Drops to Patients Undergoing Treatment Does Not Violate Anti-Kickback StatuteThe OIG determined the arrangement poses a low risk of fraud and abuse under the federal Anti-Kickback Statute and does not trigger sanctions under the beneficiary Inducements CMP.
By Vasilios J. (Bill) Kalogredis and Rachel E. (Lusk) Klebanoff
6 minute read
June 04, 2013 | The Legal Intelligencer
Sunshine Act: Implications for PhysiciansBy September 30, 2014, the Centers for Medicare and Medicaid Services (CMS) will begin publishing data on financial relationships between drug and device manufacturers and health care providers.
By Vasilios J. "Bill" Kalogredis
7 minute read
Trending Stories